Table 1.
Angiogenesis inducer | Pro-angiogenic effect | Reference |
---|---|---|
BRAFV600E | HIF1A expression | (28) |
PI3 kinase | Increase of HIF1 α protein | (29–31) |
ET-1 | Increase of HIF1 α protein | (32) |
ROS | Increase of HIF1 α protein | (34, 71) |
NF-κB | Increase of HIF 1 α protein | (33, 34) |
MITF | HIF1A expression | (40, 46) |
NRAS (with GAB2) | VEGFA expression | (48) |
ILK | NF-κB activation, IL-6, and VEGFA expression | (61) |
Reduction of BRMS1 | Increased NF-κB activity | (62) |
ROS | NF-κB activation, ANG expression | (13) |
ROS | ATM induction | (63) |
NRF2 | VEGFA expression (ATF4- or HIF1α-dependent) | (65–69) |
UPR | VEGFA, FGF2, ANG, ANGPT2 expression | (81, 82) |
PGClα | VEGFA expression | (84) |